Healthcare Equities

The companies that provide, support or coordinate medical goods and services. This sector spans a broad range of activities – including the development and manufacture of medical equipment, pharmaceuticals and other treatments. Activities range from research to manufacturing, administration, insurance and facilities management. Our Healthcare research includes healthcare services, healthcare information technology (IT), medical devices, biotechnology, biopharmaceuticals and specialty pharmaceuticals.

Actinogen Medical (ACW)

Latest price

AUD0.03

0.00 (−2.94)
As at 28/10/2025
Market capitalisation
AUD108m
View equity

AFT Pharmaceuticals (AFT)

Latest price

NZD3.05

−0.04 (−1.29)
As at 28/10/2025
Market capitalisation
NZD320m
View equity

Alzinova (ALZ)

Latest price

SEK1.58

−0.08 (−4.81)
As at 28/10/2025
Market capitalisation
SEK166m
View equity

AOTI (AOTI)

Latest price

GBP0.35

0.00 (0.00)
As at 28/10/2025
Market capitalisation
GBP38m

Argent Biopharma (RGT)

Latest price

AUD0.08

0.00 (−1.25)
As at 28/10/2025
Market capitalisation
AUD7m
View equity

Basilea Pharmaceutica (BSLN)

Latest price

CHF46.75

−0.10 (−0.21)
As at 28/10/2025
Market capitalisation
CHF623m
View equity

Biomea Fusion (BMEA)

Latest price

USD1.38

−0.04 (−2.82)
As at 28/10/2025
Market capitalisation
USD83m
View equity

Cantargia (CANTA)

Latest price

SEK2.96

−0.08 (−2.63)
As at 28/10/2025
Market capitalisation
SEK736m
View equity

Cereno Scientific (CRNO-B)

Latest price

SEK7.48

−0.20 (−2.54)
As at 28/10/2025
Market capitalisation
SEK2,203m
View equity

Chosa (CHOSA)

Latest price

SEK1.16

−0.03 (−2.52)
As at 28/10/2025
Market capitalisation
SEK92m
View equity

Creo Medical (CREO)

Latest price

GBP0.11

0.13 (1.12)
As at 28/10/2025
Market capitalisation
GBP47m
View equity

Elicera Therapeutics (ELIC)

Latest price

SEK5.88

−0.12 (−2.00)
As at 28/10/2025
Market capitalisation
SEK286m
View equity

Herantis Pharma (HRTIS)

Latest price

EUR2.25

−0.04 (−1.75)
As at 28/10/2025
Market capitalisation
EUR55m
View equity

Spotlight — flash

Healthcare

Herantis Pharma — HER-096 clears Phase Ib, eyes Phase II

Spotlight — update

Healthcare

Herantis Pharma — H125 results reflect Phase Ib progress

Spotlight — flash

Healthcare

Herantis Pharma — Last patient visit completed for Phase Ib

Hyloris Pharmaceuticals (HYL)

Latest price

EUR5.86

0.26 (4.64)
As at 28/10/2025
Market capitalisation
EUR165m

Immix Biopharma (IMMX)

Latest price

USD3.90

0.51 (15.04)
As at 28/10/2025
Market capitalisation
USD129m
View equity

IRLAB Therapeutics (IRLAB-A)

Latest price

SEK2.33

−0.12 (−4.71)
As at 28/10/2025
Market capitalisation
SEK198m
View equity